Search results
- 21.04Add to watchlist-0.02 (-0.09%)At close: Fri. May 10, 2024 4:00 PM EDT · Delayed Quote (USD) · Pre-Market Time
- Open21.10High21.25Low20.93
- Mkt CapN/AP/E (TTM)8.85Div & Yield1.25 & 5.94%
- Prev. Close21.0652 Wk. Low18.2052 Wk. High22.80
Related stocks
Tissue-type plasminogen activator, short name tPA, is a protein that facilitates the breakdown of blood clots. It acts as an enzyme to convert plasminogen into its active form plasmin, the major enzyme responsible for clot breakdown. It is a serine protease ( EC 3.4.21.68) found on endothelial cells lining the blood vessels.
Oct 6, 2023 · Tissue plasminogen activator (tPA) is a drug given through a vein to help break up a blood clot so that blood flow can return to normal. It is used for the emergency treatment of ischemic stroke, which occurs when a blood clot interrupts blood flow to a region of the brain. The timely administration of tPA can save lives.
Feb 20, 2023 · Continuing Education Activity. Tissue plasminogen activator (tPA) is classified as a serine protease (enzymes that cleave peptide bonds in proteins). It is thus one of the essential components of the dissolution of blood clots. Its primary function includes catalyzing the conversion of plasminogen to plasmin, the primary enzyme involved in ...
Known by the generic name alteplase and marketed as Activase® (Genentech), tPA is given to patients through an IV in the arm, and it works by dissolving blood clots that block blood flow to the brain.
Dec 6, 2023 · What Is TPA and Why Is It Used for Strokes? Tissue plasminogen activator is a powerful agent that dissolves blood clots. It is injected by intravenous administration (IV) for emergency stroke treatment. A stroke is caused by an interruption in blood flow either due to a blood clot ( ischemic stroke) or a bleed ( hemorrhagic stroke) in the brain.
Jan 1, 1998 · Tissue plasminogen activator (t-PA) was demonstrated to be effective in the first 3 hours after acute ischemic stroke in a pivotal randomized clinical trial sponsored by the National Institutes of Neurological Disorders and Stroke (NINDS). 1 Questions regarding the safety and efficacy of t-PA in clinical practice still persist, in part because a...
Mar 28, 2023 · Tissue plasminogen activator (tPA) is a medication that doctors administer following a stroke caused by a blood clot. It breaks up the blood clot to allow blood flow to return to the brain....
